Retinoic acid receptor agonist Am80 inhibits CXCL2 production from microglial BV-2 cells via attenuation of NF-κB signaling
- 1 September 2016
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 38, 367-376
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (26670036, 16H04673, 16K15204)
- MEXT (H24-I02)
This publication has 40 references indexed in Scilit:
- Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitisJournal of Neuroinflammation, 2015
- Immune attack: the role of inflammation in Alzheimer diseaseNature Reviews Neuroscience, 2015
- Macrophage subsets and microglia in multiple sclerosisActa Neuropathologica, 2014
- Microglia Development and FunctionAnnual Review of Immunology, 2014
- Microglial Responses after Ischemic Stroke and Intracerebral HemorrhageJournal of Immunology Research, 2013
- Innate Inflammation in Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Microglia and neurodegeneration: The role of systemic inflammationGlia, 2012
- TRPM2 Contributes to Inflammatory and Neuropathic Pain through the Aggravation of Pronociceptive Inflammatory Responses in MiceJournal of Neuroscience, 2012
- Ehrlichia chaffeensis Induces Monocyte Inflammatory Responses through MyD88, ERK, and NF-κB but Not through TRIF, Interleukin-1 Receptor 1 (IL-1R1)/IL-18R1, or Toll-Like ReceptorsInfection and Immunity, 2011
- ABCG2 reduces ROS‐mediated toxicity and inflammation: a potential role in Alzheimer’s diseaseJournal of Neurochemistry, 2010